Related Experiment Video
Updated: Mar 6, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.8K
Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population
A P Glaser1, D K Bowen1, B W Lindgren2
1Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Journal of Pediatric Urology
|March 7, 2017
Summary
Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) is feasible in adolescents for testicular cancer and other masses. Further research is needed to confirm long-term outcomes of this robotic technique.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) builds upon laparoscopic techniques.
- The da Vinci Xi® system offers enhanced benefits for RA-RPLND.
Purpose of the Study:
- To demonstrate the use of the da Vinci Xi® system for RA-RPLND in adolescent patients.
- To report on the feasibility and initial outcomes of RA-RPLND in two adolescent cases.
Main Methods:
- RA-RPLND performed on two adolescent males using the da Vinci Xi® system.
- Case 1: 17-year-old male with non-seminomatous germ cell tumor post-orchiectomy.
- Case 2: 15-year-old male with ectomesenchymoma post-excision and orchiectomy.
Main Results:
- Both procedures were nerve-sparing RA-RPLND (modified-template left, complete bilateral).
- No tumor found in 16 (Case 1) and 42 (Case 2) dissected lymph nodes.
- Minimal blood loss (<50 cc) and average console time of 262 minutes.
Conclusions:
- RA-RPLND is technically feasible in the adolescent population.
- Further studies are required to establish long-term outcomes for RA-RPLND in adolescents.
- RA-RPLND adoption is increasing, necessitating outcome data.
